Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Y Warren

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
EMBO Molecular Medicine|April 17, 2014
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle networkAntonio Ramos-Montoya, Alastair D Lamb, Roslin Russell, et al.
The American Journal of Surgical Pathology|May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaGeert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Endocrine-Related Cancer|September 1, 2016
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panelBenjamin C Thomas, Jonathan D Kay, Suraj Menon, et al.
European Urology Oncology|October 15, 2025
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility StudyChiara Re, James P Blackmur, Teele Kuusk, et al.
Nature Communications|January 25, 2022
Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancerNikita Sushentsev, Mary A McLean, Anne Y Warren, et al.
Nature Communications|March 8, 2022
Author Correction: Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancerNikita Sushentsev, Mary A McLean, Anne Y Warren, et al.
Nature|June 8, 2022
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancerSaroor A Patel, Shoko Hirosue, Paulo Rodrigues, et al.
Communications Medicine|January 13, 2026
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised <sup>13</sup>C-MRI and mass spectrometry imagingInes Horvat-Menih, Ruth Casey, James Denholm, et al.
Nature Communications|December 20, 2022
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progressionMarco Sciacovelli, Aurelien Dugourd, Lorea Valcarcel Jimenez, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
EMBO Molecular Medicine|April 17, 2014
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle networkAntonio Ramos-Montoya, Alastair D Lamb, Roslin Russell, et al.
The American Journal of Surgical Pathology|May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaGeert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Endocrine-Related Cancer|September 1, 2016
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panelBenjamin C Thomas, Jonathan D Kay, Suraj Menon, et al.
European Urology Oncology|October 15, 2025
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility StudyChiara Re, James P Blackmur, Teele Kuusk, et al.
Nature Communications|January 25, 2022
Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancerNikita Sushentsev, Mary A McLean, Anne Y Warren, et al.
Nature Communications|March 8, 2022
Author Correction: Hyperpolarised <sup>13</sup>C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancerNikita Sushentsev, Mary A McLean, Anne Y Warren, et al.
Nature|June 8, 2022
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancerSaroor A Patel, Shoko Hirosue, Paulo Rodrigues, et al.
Communications Medicine|January 13, 2026
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised <sup>13</sup>C-MRI and mass spectrometry imagingInes Horvat-Menih, Ruth Casey, James Denholm, et al.
Nature Communications|December 20, 2022
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progressionMarco Sciacovelli, Aurelien Dugourd, Lorea Valcarcel Jimenez, et al.
Pageof 14